Argenica Therapeutics Ltd has released a press release.
ARG007 (Xaranetide) Completes All Three FDA Requested Assays
Earlier from Argenica Therapeutics
- WHO Confirms Xaranetide as INN for ARG-007
- IND Application Advanced With Successful Completion of Assay
- Clinical Advisory Committee Established to Advance Phase 2b
- Presentations at European Stroke Organisation Conference